₹1,963.05-1.95 (-0.10%)
5-Dec-2025₹1,963.40-12.70 (-0.64%)
5-Dec-2025BSE : 524742
NSE : CAPLIPOINT
Sector : Health care
ISIN Code : INE475E01026
Last Updated: 05-Dec-2025
| Market Cap (₹ Cr) | 14,919 |
Traded Value (₹ Cr) | 0.61 |
Volume (Shares) | 3,114 |
Face Value (₹) | 2 |
52-Week High (₹) | 2,636.00 |
52-Week High Date | 27-Dec-2024 |
52-Week Low (₹) | 1,551.05 |
52-Week Low Date | 07-Apr-2025 |
All Time High (₹) | 2,636.00 |
All Time High Date | 27-Dec-2024 |
All Time Low (₹) | 0.18 |
All Time Low Date | 27-Feb-2002 |
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 14,922 |
| EPS - TTM (₹) [C] | 78.45 |
| P/E Ratio (X) [C] | 25.03 |
| Face Value (₹) | 2 |
| Latest Dividend (%) | 150.00 |
| Latest Dividend Date | 12-Sep-2025 |
| Dividend Yield (%) | 0.31 |
| Book Value Share (₹) [C] | 415.64 |
| P/B Ratio (₹) [C] | 4.72 |
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| UTI-Small Cap Fund - Direct (IDCW) | 69.39 | 3,63,149 | 1.44 |
| UTI-Small Cap Fund - Direct (G) | 69.39 | 3,63,149 | 1.44 |
| UTI-Small Cap Fund (IDCW) | 69.39 | 3,63,149 | 1.44 |
| UTI-Small Cap Fund (G) | 69.39 | 3,63,149 | 1.44 |
| UTI-Large & Mid Cap Fund (IDCW) | 55.58 | 2,90,883 | 1.01 |
| UTI-Large & Mid Cap Fund (G) | 55.58 | 2,90,883 | 1.01 |
| UTI-Large & Mid Cap Fund - Direct (G) | 55.58 | 2,90,883 | 1.01 |
| UTI-Large & Mid Cap Fund - Direct (IDCW) | 55.58 | 2,90,883 | 1.01 |
| UTI-Aggressive Hybrid Fund (IDCW) | 51.12 | 2,67,535 | 0.76 |
| UTI-Aggressive Hybrid Fund - Direct (G) | 51.12 | 2,67,535 | 0.76 |
Load more
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
| Today's Low/High (₹) | 1,923.60 1,980.00 |
| Week Low/High (₹) | 1,871.50 1,985.00 |
| Month Low/High (₹) | 1,871.50 2,019.00 |
| Year Low/High (₹) | 1,599.00 2,641.00 |
| All time Low/High (₹) | 0.18 2,641.00 |
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 2.65% | 2.75% | 0.01% | -0.06% |
| 1 Month | -1.80% | -1.59% | 2.70% | 2.30% |
| 3 Month | -8.10% | -8.18% | 6.20% | 5.84% |
| 6 Month | -7.36% | -7.51% | 5.24% | 5.80% |
| 1 Year | -17.25% | -17.52% | 4.83% | 5.98% |
| 3 Year | 156.25% | 156.45% | 36.41% | 40.03% |
Chairman & Non Executive Dir. : C C Paarthipan
Non Independent Executive Director / MD : Sridhar Ganesan
Independent Non Exe. Director : R Vijayaraghavan
Independent Non Exe. Director : C K Gariyali
Independent Non Exe. Director : Deenadayalan Singaram
Independent Non Exe. Director : R Nagendran
Co. Sec. / Comp. Officer / General Counsel : VENKATRAM GANAPATHYSUBRAMANIAN
Additional Director : K C John
Vice Chairman & Additional Director : ASHOK GORKEY PARTHEEBAN
Vice Chairman & Additional Director : PARTHEEBAN VIVEK SIDDARTH
Registered Office: Ashvich Towers 3rd Floor, No 3 Developed Plots Ind Estat,Chennai,Tamil Nadu-600096 Ph: 91-44-24968000/71148000/28156653
1. What's the Caplin Point Laboratories Ltd share price today?
Caplin Point Laboratories Ltd share price was Rs 1,963.05 at close on 5th Dec 2025. Caplin Point Laboratories Ltd share price was down by 0.10% from the previous closing price of Rs 1,965.00. Caplin Point Laboratories Ltd share price trend:
2. How can I quickly analyse the performance of the Caplin Point Laboratories Ltd stock?
The performance of the Caplin Point Laboratories Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Caplin Point Laboratories Ltd?
Caplin Point Laboratories Ltd has a market capitalisation of Rs 14,919 crore.
4. What is Caplin Point Laboratories Ltd's 52-week high/low share price?
The Caplin Point Laboratories Ltd’s 52-week high share price is Rs 2,636.00 and 52-week low share price is Rs 1,551.05.
5. Is the Caplin Point Laboratories Ltd profitable?
On a consolidated basis, Caplin Point Laboratories Ltd reported a profit of Rs 160.23 crore on a total income of Rs 564.43 crore for the quarter ended 2025.
6. Which are Caplin Point Laboratories Ltd’s peers in the Health care sector?
Caplin Point Laboratories Ltd’s top 5 peers in the Health care sector are Alembic Pharma, Jubilant Pharmo, Natco Pharma, Caplin Point Lab, Concord Biotech, Acutaas Chemical, Granules India.
7. Who owns how much in Caplin Point Laboratories Ltd?
Key changes to the Caplin Point Laboratories Ltd shareholding are as follows: